Mallinckrodt to settle U.S. drug marketing probe, fight kickback case Medical Dialogues Bureau6 Jun 2019 9:22 AM ISTMallinckrodt Plc on Wednesday said it had tentatively agreed to pay $15.4 million to resolve a U.S. Justice Department probe into how a drugmaker it...
India calls for expanding antiretroviral therapy coverage to combat HIV/AIDS Farhat Nasim6 Jun 2019 9:22 AM ISTIn India, a landmark HIV and AIDS (Prevention and Control) Act came into force from September 10 last year that provides a rights-based framework to...
Experts differ on ICMR suggestion on banning e-cigarettes, ENDS devices Medical Dialogues Bureau5 Jun 2019 12:45 PM ISTNew Delhi: A section of experts have said banning Electronic Nicotine Delivery Systems (ENDS), including e-cigarettes, without proper research will...
Fortis Healthcare gets BSE,NSE nod for reclassification of promoters Medical Dialogues Bureau5 Jun 2019 12:39 PM ISTNEW DELHI: Fortis Healthcare on Monday said it has received approval from both bourses BSE and NSE for reclassification of its promoters including...
Aurobindo Pharma gets 10 observations from USFDA for its Unit 3 at Hyderabad Medical Dialogues Bureau5 Jun 2019 12:28 PM ISTNew Delhi: Drug firm Aurobindo Pharma Tuesday said it has received 10 observations from the US health regulator for its Unit 3 in Hyderabad.The United...
Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug Medical Dialogues Bureau5 Jun 2019 12:27 PM ISTHyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleging that Natco Pharma and its US partner Syneos...
Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension Farhat Nasim5 Jun 2019 10:00 AM ISTBosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
Dr Reddys Labs relaunches Zenatane-generic version of Accutane in US Farhat Nasim4 Jun 2019 11:52 AM ISTZenatane (lsotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg is being launched with an approved Risk Evaluation and Mitigation Strategy (REMS)...
Merck wins USFDA approval for antibiotic Zerbaxa to treat pneumonia Medical Dialogues Bureau4 Jun 2019 9:50 AM ISTThe approval is based on the treatment's late-stage trial results, which showed that Merck's drug, Zerbaxa, was as effective as another antibacterial...
Manipal Group appoints Subrat Mohanty as Group President Medical Dialogues Bureau4 Jun 2019 9:45 AM ISTPrior to assuming his current role, Subrat Mohanty was the COO at HDFC Life responsible for a wide range of functions including Strategy, Operations,...
Domestic growth helped Indian pharma companies offset pricing pressure in US: Fitch Medical Dialogues Bureau4 Jun 2019 9:30 AM ISTMany of the leading pharma companies reported double-digit growth in their domestic sales which in turn supported overall industry growth of 11 per...
Astellas Pharma, Seattle Genetics drug shows rapid tumour shrinkage in advanced bladder cancer Medical Dialogues Bureau4 Jun 2019 9:00 AM ISTIn the 125-patient study of the drug, enfortumab vedotin, the overall response rate was 44%, meaning tumours were at least 30% smaller for those...
